Alicia Morgans

Dana-Farber Cancer Institute

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (14)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (8)

Andrew Armstrong

Professor

Duke Cancer Institute

UNITED STATES

View details

Gerhardt Attard

UNITED KINGDOM

View details

Patricia Carter

Professor

University of Texas Medical Branch at Galveston

UNITED STATES

View details

Stacey Kenfield

University of California, San Francisco

UNITED STATES

View details

Stacy Loeb

Professor

NYU School of Medicine

UNITED STATES

View details

Heather H. Cheng

University of Washington

UNITED STATES

View details

Thenappan Chandrasekar

UNITED STATES

View details

Muhieddine Labban

Chief Research Fellow

Brigham and Women's Hospital

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Alicia Morgans

Research Interests

Explore related searches

Contact this professor

Articles (14)

Navigating therapeutic sequencing in the metastatic castration-resistant prostate cancer patient journey

Pain and Its Association with Survival for Black and White Individuals with Advanced Prostate Cancer in the United States

Testosterone recovery post discontinuation of androgen deprivation for the treatment of advanced prostate cancer

Feasibility of a novel wearable thermal device for management of bothersome hot flashes in patients with prostate cancer

Sleep disturbances are underappreciated in prostate cancer survivorship

Prostate-specific antigen response and clinical progression-free survival in Black and White men with chemotherapy-naïve metastatic castration-resistant prostate cancer treated with enzalutamide in a real-world setting

Neurocognitive impairment associated with traditional and novel androgen receptor signaling inhibitors ± androgen deprivation therapy: a pharmacovigilance study

Management of Prostate Cancer in Older Adults

Health-related quality of life in patients with metastatic hormone-sensitive prostate cancer treated with androgen receptor signaling inhibitors: the role of combination treatment therapy

Treatment decision-making among patients with metastatic prostate cancer: Impact of decision locus of control on functional outcomes and decision satisfaction

An economic evaluation of cabazitaxel versus a second androgen receptor-targeted agent (ARTA) for patients with metastatic castration-resistant prostate cancer previously treated with docetaxel and an ARTA: the United States payer perspective

Isn't Androgen Deprivation Enough? Optimal Treatment for Newly Diagnosed Metastatic Prostate Cancer

Quality of Life in Men With Prostate Cancer Randomly Allocated to Receive Docetaxel or Abiraterone in the STAMPEDE Trial

Association of Race With Cancer-Related Financial Toxicity

Collaborators (8)

Andrew Armstrong

Gerhardt Attard

Patricia Carter

Stacey Kenfield

Stacy Loeb

Heather H. Cheng

Thenappan Chandrasekar

Muhieddine Labban

Make your next move.